| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/30/2008 | CN100406005C Compound and method for therapeutic intervention in preventing diabetic complications |
| 07/30/2008 | CA2619799A1 Methods for evaluating and implementing prostate disease treatments |
| 07/29/2008 | US7405323 Invention provides five novel polymorphic forms of modafinil racemate called CRL 40476 form III, CRL 40476 form IV, CRL 40476 form V, CRL 40476 form VI, CRL 40476 form VII; preparing a new solvate of modafinil comprising dissolving in solvent and crystallizing; sleep disorders |
| 07/29/2008 | US7405311 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus |
| 07/29/2008 | US7405310 Non-nucleoside reverse transcriptase inhibitors |
| 07/29/2008 | US7405309 e.g. iodomethylene-dimethyl-dihydropyranone; novelty of the chemical structure and of the mechanism of action; alkylation aldehyde with methyl [bis(2,2,2-trifluoroethyl)phosphinoyl]acetate followed by cyclization |
| 07/29/2008 | US7405307 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; antiobesity and anti-type II diabetic agents |
| 07/29/2008 | US7405306 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 07/29/2008 | US7405305 Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors |
| 07/29/2008 | US7405303 e.g. 4-[(7-Hydroxy-2-ethyl-3-phenyl-4-quinolinyl)oxyphenyl]-2-propenoic acid; bone diseases, aging, osteoporosis, osteoarthritis, atherosclerosis, menopausal disorders,liver and cardiovascular disorder, breast cancer |
| 07/29/2008 | US7405300 Central nervous system disorders; cardiovascular disorders; antiischemic agents; strokes; antiarthritic agents; anticancer agents; muscular disorders |
| 07/29/2008 | US7405297 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one |
| 07/29/2008 | US7405295 Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds |
| 07/29/2008 | US7405240 Use treating glaucoma, ocular hypertension, or baldness; prostaglandin EP2 selective agonists are 1-hydroxy-3-chloro-4-carboxylalk(en)yl-5-(aryloxyalkyl)cyclopentanes |
| 07/29/2008 | US7405239 Acylhydrazone derivatives and the use thereof in the inhibition, regulation and/or modulation of kinase signal transduction |
| 07/29/2008 | US7405238 Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| 07/29/2008 | US7405237 Isoindoline compounds and methods of their use |
| 07/29/2008 | US7405236 e.g. {6-[5-(4-trifluoromethoxy-phenyl)-pent-4-ynyloxy]-indol-1-yl}-acetic acid; peroxisome proliferator activated receptor PPAR delta or PPAR alpha agonist; antidiabetic, antiinflammatory agent, cardiovascular disorders; non-insulin dependent diabetes, insulin resistance, atherosclerosis |
| 07/29/2008 | US7405235 Benzimidazoles for antibiotic resistance of cells |
| 07/29/2008 | US7405234 Bicyclic modulators of androgen receptor function |
| 07/29/2008 | US7405233 e.g. 3-[3-(4-ISOPROPYLPHENYL)-2,5-DIOXO-IMIDAZOLIDIN-1-YL]-BENZOIC ACID SODIUM SALT; method of modulating premature translation termination and/or nonsense-mediated mRNA decay in a cell in vitro; cystic fibrosis or Duchenne muscular dystrophy |
| 07/29/2008 | US7405232 Long acting beta-2 agonists and their use as medicaments |
| 07/29/2008 | US7405231 Oxidized thioether derivatives |
| 07/29/2008 | US7405230 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 07/29/2008 | US7405229 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 07/29/2008 | US7405228 Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoprotein sites |
| 07/29/2008 | US7405226 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses |
| 07/29/2008 | US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 07/29/2008 | US7405224 Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions |
| 07/29/2008 | US7405223 Treating allergic and inflammatory conditions |
| 07/29/2008 | US7405222 Administering a drug, e.g., a vasodilator, by intracavernosal pharmacotherapy after assessing the general, physical and psychological condition of the male, determining a test dosage and adjusting the dosage to provide suitable results |
| 07/29/2008 | US7405221 2-(4-fluorobenzyloxy)-4-(2,4-dichlorophenyl)-5-(4-chlorophenyl)pyrimidine; antagonists or inverse agonists of the Cannabinoid-1 (CB1) receptor; antidepressant, neuroleptic, anxiolytic, antiinflammatory agent, cognition activator; psychosis, epilepsy, Parkinson's disease, and schizophrenia |
| 07/29/2008 | US7405220 Pyrazolopyrimidines |
| 07/29/2008 | US7405219 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine; adenosine receptor antagonist; antidepressant, neurodegenerative disorders, cognition activator, attention deficit disorder |
| 07/29/2008 | US7405218 Isothiazole derivatives useful as anticancer agents |
| 07/29/2008 | US7405217 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/29/2008 | US7405216 Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate) |
| 07/29/2008 | US7405215 e.g. [3-(3-benzyl-4-oxo-3,4-dihydro-phthalazin-1-yl)-indol-1-yl]-acetic acid; inhibit binding of endogenous ligands, including prostaglandin PGD2 and its metabolites and certain thromboxane metabolites (such as 11-dehydro-TXB2), to CRTH2; antiallergent; asthma, bronchitis, rhinitis, cough, psoriasis |
| 07/29/2008 | US7405214 Antitumor agents; 2-fluoro-cyclopentenyl nucleosides such as 4-Amino-1-(2-fluoro-4-hydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-one; synthesis using 1-((4S,5S)-2,2-Dimethyl-5-vinyl-1,3-dioxolan-4-yl)-2-trityloxy-ethanone intermediates |
| 07/29/2008 | US7405213 such as 3-chloro-4-fluoro-N-(5-{[6-({3-[4-(hydroxymethyl)piperidin-1-yl]propyl}oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-4-yl]amino}pyrimidin-2-yl)benzamide; serine/threonine Aurora kinase inhibitor; anticarcinogenic agent |
| 07/29/2008 | US7405211 Therapeutic morpholino-substituted compounds |
| 07/29/2008 | US7405210 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase |
| 07/29/2008 | US7405209 Protease inhibitors |
| 07/29/2008 | US7405208 Benzoquinone ansamycins |
| 07/29/2008 | US7405207 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof |
| 07/29/2008 | US7405206 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound |
| 07/29/2008 | US7405204 Nucleoside compounds for treating viral infections |
| 07/29/2008 | US7405200 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
| 07/29/2008 | US7405194 Therapeutic agents and methods of use thereof for the treatment of melanoma |
| 07/29/2008 | US7405080 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 07/29/2008 | US7404970 Pain relief composition, method to form same, and method to use same |
| 07/29/2008 | US7404968 unit aliquot dose of a pharmaceutical electricstatically deposited on a porous, permeable or semi-permeable ingestible membrane; including two or more active pharmaceuticals segregated from one another in a single delivery package. |
| 07/29/2008 | US7404967 A water-soluble divalent strontium cation in a suitable topical formulation vehicle; preferably, strontium nitrate, strontium chloride and strontium acetate; cosmetics; drugs soaps; detergents; antiallergens |
| 07/29/2008 | US7404964 Complex of antibiotic and fatty acid; sustained release; extended release time, maximum stability and efficacy, reduced toxicity, maximum reproducibility in preparation, and the elimination of unwanted physical, biochemical, or toxicological effects introduced by undesirable matrix materials |
| 07/29/2008 | US7404962 Combination kit used in the treatment of malaria |
| 07/29/2008 | US7404954 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms |
| 07/29/2008 | US7404951 Intravenously administering glutamate modifying enzyme and co-factor to enhance brain to blood efflux; transaminase, dehydrogenase, decarboxylase, ligase |
| 07/29/2008 | CA2515596C Cannabinoid receptor ligands and uses thereof |
| 07/29/2008 | CA2460939C Substituted pyrazolyl compounds for the treatment of inflammation |
| 07/29/2008 | CA2438813C Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2409842C 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 07/29/2008 | CA2405486C Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 07/29/2008 | CA2401952C Pyranoindoles for treating glaucoma |
| 07/29/2008 | CA2401033C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/29/2008 | CA2387762C Process of making substituted pyrazoles |
| 07/29/2008 | CA2383600C Method for determining viability of a myocardial segment |
| 07/29/2008 | CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 07/29/2008 | CA2381729C Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| 07/29/2008 | CA2377614C Anesthetic composition for intravenous injection comprising propofol |
| 07/29/2008 | CA2376930C A method for the treatment or prevention of coronary graft vasospasm |
| 07/29/2008 | CA2376303C Stabilized vitamin c formulations |
| 07/29/2008 | CA2375601C Carbapenem compound crystals and injection preparations |
| 07/29/2008 | CA2375383C Modulators of methylation for control of bacterial virulence |
| 07/29/2008 | CA2374442C Silicone gel containing salicylic acid |
| 07/29/2008 | CA2371857C Gardos channel antagonists |
| 07/29/2008 | CA2368413C Derivatives of pyrimido[6,1-a]isoquinolin-4-one |
| 07/29/2008 | CA2367214C Method for a programmed controlled ovarian stimulation protocol |
| 07/29/2008 | CA2362343C Method and composition for treating acne |
| 07/29/2008 | CA2362217C Process for preparing phenylpyrazole pesticidal intermediates |
| 07/29/2008 | CA2359592C Pharmaceutical compositions for alleviating discomfort |
| 07/29/2008 | CA2352149C Solid lipidic nanospheres suitable to a fast internalization into cells |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2344893C Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders |
| 07/29/2008 | CA2337755C Inhibitors of p38 |
| 07/29/2008 | CA2336799C Improved stable topical ascorbic acid compositions |
| 07/29/2008 | CA2333656C A novel vla-4 inhibitor: omepupa-v |
| 07/29/2008 | CA2333008C New heterocyclically substituted amides, their production and their use |
| 07/29/2008 | CA2328950C Piperidinopyrimidine derivatives for topical application |
| 07/29/2008 | CA2324077C Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 07/29/2008 | CA2323315C Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds |
| 07/29/2008 | CA2307002C Antitumour uridine analogues |
| 07/29/2008 | CA2295628C Stable formulations comprising a nucleotide and a freeze drying additive |
| 07/29/2008 | CA2291685C Pharmaceutical product for the detection of helicobacter pylori-induced gastrointestinal disorder |
| 07/29/2008 | CA2286822C Kodaistatins a, b, c and d, a process for their production and their use |
| 07/29/2008 | CA2285909C Biodegradable polymers chain-extended by phosphates, compositions, articles and methods for making and using the same |
| 07/29/2008 | CA2281817C Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria |
| 07/29/2008 | CA2275371C Phenylethylamine derivatives |
| 07/29/2008 | CA2272732C Hemorrhoidal treatment composition |